Some notable recent reports of the Congressional Research Service that have not been readily available to the public include the following:
“China and Proliferation of Weapons of Mass Destruction and Missiles: Policy Issues” (pdf), updated April 6, 2006.
“Protection of Classified Information by Congress: Practices and Proposals” (pdf), updated April 5, 2006.
“Navy Ship Propulsion Technologies: Options for Reducing Oil Use — Background for Congress” (pdf), April 12, 2006.
“FY2006 Supplemental Appropriations: Iraq and Other International Activities; Additional Katrina Hurricane Relief” (pdf), updated April 14, 2006.
“Immigration Enforcement Within the United States” (pdf), April 6, 2006.
“Patent Reform: Issues in the Biomedical and Software Industries” (pdf), April 7, 2006.
“Oil Shale: History, Incentives, and Policy” (pdf), April 13, 2006.
As surrogate markers are increasingly being accepted by FDA to support approval of new drugs and biologics, it is imperative that patients and clinicians understand whether such novel endpoints are reflective of meaningful clinical benefits.
The Secretary of Health and Human Services should launch a Department-wide initiative to reduce wasteful spending on health services, drugs, and ineffective medical devices, saving many lives as well as billions of dollars annually.
Now that the One Big Beautiful Bill is law, the elimination of clean energy tax credits will cause a nation of higher energy bills – even for consumers and states that aren’t using clean energy.
Bureaucracy significantly hinders federally funded scientific research, diverting scientists’ time from discovery to low-value administrative tasks.